Morten Schak Nielsen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Morten Schak Nielsen has a total of 209 co-authors. Here are the top co-authors by number of shared publications:
- Niels-Henrik Holstein-Rathlou
University of Copenhagen
15 shared publications - Nanna MacAulay
University of Copenhagen
8 shared publications - Mario Delmar
The Leon Charney Division of Cardiology New York University Grossman School of Medicine New York New York USA
7 shared publications Johannes P. Hofgaard
Department of Biomedical Sciences and The Danish National Research Foundation Centre for Cardiac Arrhythmia, Faculty of Health and Medical Sciences, University of Copenhagen Copenhagen, Denmark
5 shared publications- Thomas Hartig Braunstein
University of Copenhagen
5 shared publications - Brian Skriver Nielsen
Department of Growth and Reproduction, Copenhagen University Hospital—Rigshospitalet , Copenhagen
4 shared publications
Latest Publications
- Open Access
Ephaptic coupling enables action potential conduction
Background: Cardiac action potentials are believed to propagate solely by electrotonic transmission via gap junctions. In the alternative theory of ephaptic transmission, changes in extracellular electrical fields and ion concentrations may enable a cardiomyocyte to activate its neighbors. The involvement of ephaptic mechanisms remain highly disputed and has been discounted due to the reported inability of an isolated cardiomyocyte to activate another. Methods: Isolated rat cardiomyocytes were subjected to whole cell patch clamp. Transmission of action potentials was tested in current clamp in isolated cardiomyocytes pushed together and in native cardiomyocyte pairs. Sodium channel activation and inactivation was tested in voltage clamp. Results: Isolated cardiomyocytes were pushed together end-to-end and one stimulated to fire an action potential. In 10 attempts, 2 pairs showed successful transmission of action potentials, showing that ephaptic transmission is possible. In native pairs, subthreshold depolarization was transferred between cardiomyocytes of native electrically coupled pairs, however, only after a delay, which is not be explained from electrotonic theory. Once action potentials were elicited in one cardiomyocyte of a native pair, the neighbor was activated with delays under 2 msec. The activation delay did not correlate with gap junctional coupling, again suggesting the presence of an alternative mechanism. In voltage clamp of native cardiomyocyte pairs, one cardiomyocyte was held at -90 mV while depolarizing pulses were applied to its neighbor. Consistently, activation of sodium channels in the depolarized cell led to activation of sodium channels in the hyperpolarized cell, which fits well with ephaptic but not electrotonic theory. Ephaptic transmission requires a shielded local domain. To separate this, we measured steady state inactivation in native pairs. As expected, all channels inactivated at -40 mV. However, when maintaining a potential of – 40 mV for an extended period, sodium current elicited at 0 mV re-emerged by de-inactivation. The de-inactivation at -40 mV support that a shielded domain exists where potassium currents can hyperpolarize the local potential. Conclusions: We show for the first time that ephaptic transmission is possible, that it is most likely in operation, also in the presence of gap junctional coupling, and finally our study suggests that data obtained in single cells may fail to reproduce key features of the electrophysiology of cardiomyocytes that interact with neighboring cardiomyocytes.
Open AccessEphaptic coupling enables action potential conduction
Background: Cardiac action potentials are believed to propagate solely by electrotonic transmission via gap junctions. In the alternative theory of ephaptic transmission, changes in extracellular electrical fields and ion concentrations may enable a cardiomyocyte to activate its neighbors. The involvement of ephaptic mechanisms remain highly disputed and has been discounted due to the reported inability of an isolated cardiomyocyte to activate another. Methods: Isolated rat cardiomyocytes were subjected to whole cell patch clamp. Transmission of action potentials was tested in current clamp in isolated cardiomyocytes pushed together and in native cardiomyocyte pairs. Sodium channel activation and inactivation was tested in voltage clamp. Results: Isolated cardiomyocytes were pushed together end-to-end and one stimulated to fire an action potential. In 10 attempts, 2 pairs showed successful transmission of action potentials, showing that ephaptic transmission is possible. In native pairs, subthreshold depolarization was transferred between cardiomyocytes of native electrically coupled pairs, however, only after a delay, which is not be explained from electrotonic theory. Once action potentials were elicited in one cardiomyocyte of a native pair, the neighbor was activated with delays under 2 msec. The activation delay did not correlate with gap junctional coupling, again suggesting the presence of an alternative mechanism. In voltage clamp of native cardiomyocyte pairs, one cardiomyocyte was held at -90 mV while depolarizing pulses were applied to its neighbor. Consistently, activation of sodium channels in the depolarized cell led to activation of sodium channels in the hyperpolarized cell, which fits well with ephaptic but not electrotonic theory. Ephaptic transmission requires a shielded local domain. To separate this, we measured steady state inactivation in native pairs. As expected, all channels inactivated at -40 mV. However, when maintaining a potential of – 40 mV for an extended period, sodium current elicited at 0 mV re-emerged by de-inactivation. The de-inactivation at -40 mV support that a shielded domain exists where potassium currents can hyperpolarize the local potential. Conclusions: We show for the first time that ephaptic transmission is possible, that it is most likely in operation, also in the presence of gap junctional coupling, and finally our study suggests that data obtained in single cells may fail to reproduce key features of the electrophysiology of cardiomyocytes that interact with neighboring cardiomyocytes.
- 25 December 2023
- Published by Elsevier in JACC: Clinical Electrophysiology
- Vol. 9 (12) , 2475-2476
Phase-2 Re-Entry in Brugada Syndrome
- 25 December 2023
- Published by Elsevier in JACC: Clinical Electrophysiology
- Vol. 9 (12) , 2475-2476
Phase-2 Re-Entry in Brugada Syndrome
- Open Access
- 9 August 2023
- Published by Oxford University Press (OUP) in Cardiovascular Research
- Vol. 119 (13) , 2342-2354
Mitochondrial pannexin1 controls cardiac sensitivity to ischaemia/reperfusion injury
No effective therapy is available in clinics to protect the heart from ischaemia/reperfusion (I/R) injury. Endothelial cells are activated after I/R, which may drive the inflammatory response by releasing ATP through pannexin1 (Panx1) channels. Here, we investigated the role of Panx1 in cardiac I/R. Panx1 was found in cardiac endothelial cells, neutrophils, and cardiomyocytes. After in vivo I/R, serum Troponin-I, and infarct size were less pronounced in Panx1−/− mice, but leukocyte infiltration in the infarct area was similar between Panx1−/− and wild-type mice. Serum Troponin-I and infarct size were not different between mice with neutrophil-specific deletion of Panx1 and Panx1fl/fl mice, suggesting that cardioprotection by Panx1 deletion rather involved cardiomyocytes than the inflammatory response. Physiological cardiac function in wild-type and Panx1−/− hearts was similar. The time to onset of contracture and time to maximal contracture were delayed in Panx1−/− hearts, suggesting reduced sensitivity of these hearts to ischaemic injury. Moreover, Panx1−/− hearts showed better recovery of left ventricle developed pressure, cardiac contractility, and relaxation after I/R. Ischaemic preconditioning failed to confer further protection in Panx1−/− hearts. Panx1 was found in subsarcolemmal mitochondria (SSM). SSM in WT or Panx1−/− hearts showed no differences in morphology. The function of the mitochondrial permeability transition pore and production of reactive oxygen species in SSM was not affected, but mitochondrial respiration was reduced in Panx1−/− SSM. Finally, Panx1−/− cardiomyocytes had a decreased mitochondrial membrane potential and an increased mitochondrial ATP content. Panx1−/− mice display decreased sensitivity to cardiac I/R injury, resulting in smaller infarcts and improved recovery of left ventricular function. This cardioprotective effect of Panx1 deletion seems to involve cardiac mitochondria rather than a reduced inflammatory response. Thus, Panx1 may represent a new target for controlling cardiac reperfusion damage.
- 9 August 2023
- Published by Oxford University Press (OUP) in Cardiovascular Research
- Vol. 119 (13) , 2342-2354
Open AccessMitochondrial pannexin1 controls cardiac sensitivity to ischaemia/reperfusion injury
No effective therapy is available in clinics to protect the heart from ischaemia/reperfusion (I/R) injury. Endothelial cells are activated after I/R, which may drive the inflammatory response by releasing ATP through pannexin1 (Panx1) channels. Here, we investigated the role of Panx1 in cardiac I/R. Panx1 was found in cardiac endothelial cells, neutrophils, and cardiomyocytes. After in vivo I/R, serum Troponin-I, and infarct size were less pronounced in Panx1−/− mice, but leukocyte infiltration in the infarct area was similar between Panx1−/− and wild-type mice. Serum Troponin-I and infarct size were not different between mice with neutrophil-specific deletion of Panx1 and Panx1fl/fl mice, suggesting that cardioprotection by Panx1 deletion rather involved cardiomyocytes than the inflammatory response. Physiological cardiac function in wild-type and Panx1−/− hearts was similar. The time to onset of contracture and time to maximal contracture were delayed in Panx1−/− hearts, suggesting reduced sensitivity of these hearts to ischaemic injury. Moreover, Panx1−/− hearts showed better recovery of left ventricle developed pressure, cardiac contractility, and relaxation after I/R. Ischaemic preconditioning failed to confer further protection in Panx1−/− hearts. Panx1 was found in subsarcolemmal mitochondria (SSM). SSM in WT or Panx1−/− hearts showed no differences in morphology. The function of the mitochondrial permeability transition pore and production of reactive oxygen species in SSM was not affected, but mitochondrial respiration was reduced in Panx1−/− SSM. Finally, Panx1−/− cardiomyocytes had a decreased mitochondrial membrane potential and an increased mitochondrial ATP content. Panx1−/− mice display decreased sensitivity to cardiac I/R injury, resulting in smaller infarcts and improved recovery of left ventricular function. This cardioprotective effect of Panx1 deletion seems to involve cardiac mitochondria rather than a reduced inflammatory response. Thus, Panx1 may represent a new target for controlling cardiac reperfusion damage.
- 1 July 2023
- Published by American Physiological Society in Physiological Reviews
- Vol. 103 (3) , 2271-2319
The intercalated disc: a unique organelle for electromechanical synchrony in cardiomyocytes
The intercalated disc (ID) is a highly specialized structure that connects cardiomyocytes via mechanical and electrical junctions. Although described in some detail by light microscopy in the 19th century, it was in 1966 that electron microscopy images showed that the ID represented apposing cell borders and provided detailed insight into the complex ID nanostructure. Since then, much has been learned about the ID and its molecular composition, and it has become evident that a large number of proteins, not all of them involved in direct cell-to-cell coupling via mechanical or gap junctions, reside at the ID. Furthermore, an increasing number of functional interactions between ID components are emerging, leading to the concept that the ID is not the sum of isolated molecular silos but an interacting molecular complex, an “organelle” where components work in concert to bring about electrical and mechanical synchrony. The aim of the present review is to give a short historical account of the ID’s discovery and an updated overview of its composition and organization, followed by a discussion of the physiological implications of the ID architecture and the local intermolecular interactions. The latter will focus on both the importance of normal conduction of cardiac action potentials as well as the impact on the pathophysiology of arrhythmias.
- 1 July 2023
- Published by American Physiological Society in Physiological Reviews
- Vol. 103 (3) , 2271-2319
The intercalated disc: a unique organelle for electromechanical synchrony in cardiomyocytes
The intercalated disc (ID) is a highly specialized structure that connects cardiomyocytes via mechanical and electrical junctions. Although described in some detail by light microscopy in the 19th century, it was in 1966 that electron microscopy images showed that the ID represented apposing cell borders and provided detailed insight into the complex ID nanostructure. Since then, much has been learned about the ID and its molecular composition, and it has become evident that a large number of proteins, not all of them involved in direct cell-to-cell coupling via mechanical or gap junctions, reside at the ID. Furthermore, an increasing number of functional interactions between ID components are emerging, leading to the concept that the ID is not the sum of isolated molecular silos but an interacting molecular complex, an “organelle” where components work in concert to bring about electrical and mechanical synchrony. The aim of the present review is to give a short historical account of the ID’s discovery and an updated overview of its composition and organization, followed by a discussion of the physiological implications of the ID architecture and the local intermolecular interactions. The latter will focus on both the importance of normal conduction of cardiac action potentials as well as the impact on the pathophysiology of arrhythmias.
- 1 December 2020
- Published by American Dairy Science Association in Journal of Dairy Science
- Vol. 103 (12) , 12104-12108
Short communication: Effects of transition milk and milk replacer supplemented with colostrum replacer on growth and health of dairy calves
Transition milk (TM, defined here as the second through fourth milkings after calving) supplies additional fat, protein, and immunoglobulins to the calf compared with milk replacer at industry-suggested feeding rates (∼14% solids). Our objective was to determine whether 9 feedings of TM on d 2 through 4 of life increase the growth rate and overall health of calves. Holstein heifer calves on a commercial farm were randomly assigned to 1 of 3 diets (n = 35/diet): milk replacer (MR; Purina Warm Front BOV MOS Medicated Milk Replacer, St. Louis, MO), TM, or a 50:50 blend of MR and colostrum replacer (MCR; Alta HiCal Colostrum Powder Replacer, the Saskatoon Colostrum Company Ltd., Saskatoon, SK, Canada). The TM was harvested from Holstein cows on the farm, pooled, and pasteurized at 71.7°C for 15 s. Nutrient composition on a dry matter basis of TM was 25.9% fat, 41.8% protein, and 14% solids; MR was 10.3% fat, 27.8% protein, and 14% solids; and MCR was 14.6% fat, 38.6% protein, and 15% solids. All calves received IgG-enriched colostrum replacer for the first 2 feedings after birth. Subsequently, calves were fed 1.9 L of MR, TM, or MCR 3 times per day for 3 d (starting on d 2). After initial diets ended, calves were fed and managed similarly. Body weights (d 1, 7, 14, 21, and 56), blood samples (d 1, 7, 14, and 21), and daily health scores (scale of 0 to 3, with 0 representing normal or healthy and 3 representing severe symptoms or ill) were collected through weaning at 56 d. All except 1 calf achieved successful transfer of passive immunity, with serum IgG values greater than 10.0 mg/mL. From birth through weaning, calves fed TM and MCR gained 3 kg more total body weight than those fed MR (34.3, 34.3, and 31.3 kg, respectively). Increased metabolizable energy (using NRC 2001 recommendations) in TM accounts for 0.68 kg of the increased gain compared with MR. Treatment did not alter health scores for ears, eyes, or feces. Haptoglobin concentrations were lower in TM and MCR than in MR calves (4.63, 3.62, and 7.54 µg/mL, respectively), whereas lipopolysaccharide binding protein concentrations were not different. In conclusion, compared with MR alone, feeding TM or MR with colostrum replacer for 3 d increased growth rate of calves throughout the preweaning period.
- 1 December 2020
- Published by American Dairy Science Association in Journal of Dairy Science
- Vol. 103 (12) , 12104-12108
Short communication: Effects of transition milk and milk replacer supplemented with colostrum replacer on growth and health of dairy calves
Transition milk (TM, defined here as the second through fourth milkings after calving) supplies additional fat, protein, and immunoglobulins to the calf compared with milk replacer at industry-suggested feeding rates (∼14% solids). Our objective was to determine whether 9 feedings of TM on d 2 through 4 of life increase the growth rate and overall health of calves. Holstein heifer calves on a commercial farm were randomly assigned to 1 of 3 diets (n = 35/diet): milk replacer (MR; Purina Warm Front BOV MOS Medicated Milk Replacer, St. Louis, MO), TM, or a 50:50 blend of MR and colostrum replacer (MCR; Alta HiCal Colostrum Powder Replacer, the Saskatoon Colostrum Company Ltd., Saskatoon, SK, Canada). The TM was harvested from Holstein cows on the farm, pooled, and pasteurized at 71.7°C for 15 s. Nutrient composition on a dry matter basis of TM was 25.9% fat, 41.8% protein, and 14% solids; MR was 10.3% fat, 27.8% protein, and 14% solids; and MCR was 14.6% fat, 38.6% protein, and 15% solids. All calves received IgG-enriched colostrum replacer for the first 2 feedings after birth. Subsequently, calves were fed 1.9 L of MR, TM, or MCR 3 times per day for 3 d (starting on d 2). After initial diets ended, calves were fed and managed similarly. Body weights (d 1, 7, 14, 21, and 56), blood samples (d 1, 7, 14, and 21), and daily health scores (scale of 0 to 3, with 0 representing normal or healthy and 3 representing severe symptoms or ill) were collected through weaning at 56 d. All except 1 calf achieved successful transfer of passive immunity, with serum IgG values greater than 10.0 mg/mL. From birth through weaning, calves fed TM and MCR gained 3 kg more total body weight than those fed MR (34.3, 34.3, and 31.3 kg, respectively). Increased metabolizable energy (using NRC 2001 recommendations) in TM accounts for 0.68 kg of the increased gain compared with MR. Treatment did not alter health scores for ears, eyes, or feces. Haptoglobin concentrations were lower in TM and MCR than in MR calves (4.63, 3.62, and 7.54 µg/mL, respectively), whereas lipopolysaccharide binding protein concentrations were not different. In conclusion, compared with MR alone, feeding TM or MR with colostrum replacer for 3 d increased growth rate of calves throughout the preweaning period.
- Open Access
- 1 June 2020
- Published by Elsevier in Journal of Molecular and Cellular Cardiology
- Vol. 143, 63-70
Quantitative proteomics characterization of acutely isolated primary adult rat cardiomyocytes and fibroblasts
- 1 June 2020
- Published by Elsevier in Journal of Molecular and Cellular Cardiology
- Vol. 143, 63-70
Open AccessQuantitative proteomics characterization of acutely isolated primary adult rat cardiomyocytes and fibroblasts
- 6 January 2020
- Published by Wiley in The Journal of Physiology
- Vol. 598 (2) , 361-379
Pannexin 1 activation and inhibition is permeant‐selective
Key points: The large‐pore channel pannexin 1 (Panx1) is expressed in many cell types and can open upon different, yet not fully established, stimuli. Panx1 permeability is often inferred from channel permeability to fluorescent dyes, but it is currently unknown whether dye permeability translates to permeability to other molecules. Cell shrinkage and C‐terminal cleavage led to a Panx1 open‐state with increased permeability to atomic ions (current), but did not alter ethidium uptake. Panx1 inhibitors affected Panx1‐mediated ion conduction differently from ethidium permeability, and inhibitor efficiency towards a given molecule therefore cannot be extrapolated to its effects on the permeability of another. We conclude that ethidium permeability does not reflect equal permeation of other molecules and thus is no measure of general Panx1 activity. Pannexin 1 (Panx1) is a large‐pore membrane channel connecting the extracellular milieu with the cell interior. While several activation regimes activate Panx1 in a variety of cell types, the selective permeability of an open Panx1 channel remains unresolved: does a given activation paradigm increase Panx1's permeability towards all permeants equally and does fluorescent dye flux serve as a proxy for biological permeation through an open channel? To explore permeant‐selectivity of Panx1 activation and inhibition, we employed Panx1‐expressing Xenopus laevis oocytes and HEK293T cells. We report that different mechanisms of activation of Panx1 differentially affected ethidium and atomic ion permeation. Most notably, C‐terminal truncation or cell shrinkage elevated Panx1‐mediated ion conductance, but had no effect on ethidium permeability. In contrast, extracellular pH changes predominantly affected ethidium permeability but not ionic conductance. High [K+]o did not increase the flux of either of the two permeants. Once open, Panx1 demonstrated preference for anionic permeants, such as Cl−, lactate and glutamate, while not supporting osmotic water flow. Panx1 inhibitors displayed enhanced potency towards Panx1‐mediated currents compared to that of ethidium uptake. We conclude that activation or inhibition of Panx1 display permeant‐selectivity and that permeation of ethidium does not necessarily reflect an equal permeation of smaller biological molecules and atomic ions.
- 6 January 2020
- Published by Wiley in The Journal of Physiology
- Vol. 598 (2) , 361-379
Pannexin 1 activation and inhibition is permeant‐selective
Key points: The large‐pore channel pannexin 1 (Panx1) is expressed in many cell types and can open upon different, yet not fully established, stimuli. Panx1 permeability is often inferred from channel permeability to fluorescent dyes, but it is currently unknown whether dye permeability translates to permeability to other molecules. Cell shrinkage and C‐terminal cleavage led to a Panx1 open‐state with increased permeability to atomic ions (current), but did not alter ethidium uptake. Panx1 inhibitors affected Panx1‐mediated ion conduction differently from ethidium permeability, and inhibitor efficiency towards a given molecule therefore cannot be extrapolated to its effects on the permeability of another. We conclude that ethidium permeability does not reflect equal permeation of other molecules and thus is no measure of general Panx1 activity. Pannexin 1 (Panx1) is a large‐pore membrane channel connecting the extracellular milieu with the cell interior. While several activation regimes activate Panx1 in a variety of cell types, the selective permeability of an open Panx1 channel remains unresolved: does a given activation paradigm increase Panx1's permeability towards all permeants equally and does fluorescent dye flux serve as a proxy for biological permeation through an open channel? To explore permeant‐selectivity of Panx1 activation and inhibition, we employed Panx1‐expressing Xenopus laevis oocytes and HEK293T cells. We report that different mechanisms of activation of Panx1 differentially affected ethidium and atomic ion permeation. Most notably, C‐terminal truncation or cell shrinkage elevated Panx1‐mediated ion conductance, but had no effect on ethidium permeability. In contrast, extracellular pH changes predominantly affected ethidium permeability but not ionic conductance. High [K+]o did not increase the flux of either of the two permeants. Once open, Panx1 demonstrated preference for anionic permeants, such as Cl−, lactate and glutamate, while not supporting osmotic water flow. Panx1 inhibitors displayed enhanced potency towards Panx1‐mediated currents compared to that of ethidium uptake. We conclude that activation or inhibition of Panx1 display permeant‐selectivity and that permeation of ethidium does not necessarily reflect an equal permeation of smaller biological molecules and atomic ions.
- Open Access
- 1 November 2019
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 294 (45) , 16789-16803
Structural determinants underlying permeant discrimination of the Cx43 hemichannel
- 1 November 2019
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 294 (45) , 16789-16803
Open AccessStructural determinants underlying permeant discrimination of the Cx43 hemichannel
- Open Access
- 9 April 2019
- Published by Wiley in Physiological Reports
- Vol. 7 (7) , e14049
Acute intramyocardial lipid accumulation in rats does not slow cardiac conduction per se
Diabetic patients suffer from both cardiac lipid accumulation and an increased risk of arrhythmias and sudden cardiac death. This correlation suggests a link between diabetes induced cardiac steatosis and electrical abnormalities, however, the underlying mechanism remains unknown. We previously showed that cardiac conduction velocity slows in Zucker diabetic fatty rats and in fructose‐fat fed rats, models that both exhibit prominent cardiac steatosis. The aim of this study was to investigate whether acute cardiac lipid accumulation reduces conduction velocity per se. Cardiac lipid accumulation was induced acutely by perfusing isolated rat hearts with palmitate‐glucose buffer, or subacutely by fasting rats overnight. Subsequently, longitudinal cardiac conduction velocity was measured in right ventricular tissue strips, and intramyocardial triglyceride and lipid droplet content was determined by thin layer chromatography and BODIPY staining, respectively. Perfusion with palmitate‐glucose buffer significantly increased intramyocardial triglyceride levels compared to perfusion with glucose (2.16 ± 0.17 (n = 10) vs. 0.92 ± 0.33 nmol/mg WW (n = 9), P < 0.01), but the number of lipid droplets was very low in both groups. Fasting of rats, however, resulted in both significantly elevated intramyocardial triglyceride levels compared to fed rats (3.27 ± 0.43 (n = 10) vs. 1.45 ± 0.24 nmol/mg WW (n = 10)), as well as a larger volume of lipid droplets (0.60 ± 0.13 (n = 10) vs. 0.21 ± 0.06% (n = 10), P < 0.05). There was no significant difference in longitudinal conduction velocity between palmitate‐glucose perfused and control hearts (0.77 ± 0.025 (n = 10) vs. 0.75 m/sec ± 0.029 (n = 9)), or between fed and fasted rats (0.75 ± 0.042 m/sec (n = 10) vs. 0.79 ± 0.047 (n = 10)). In conclusion, intramyocardial lipid accumulation does not slow cardiac longitudinal conduction velocity per se. This is true for both increased intramyocardial triglyceride content, induced by palmitate‐glucose perfusion, and increased intramyocardial triglyceride and lipid droplet content, generated by fasting.
- 9 April 2019
- Published by Wiley in Physiological Reports
- Vol. 7 (7) , e14049
Open AccessAcute intramyocardial lipid accumulation in rats does not slow cardiac conduction per se
Diabetic patients suffer from both cardiac lipid accumulation and an increased risk of arrhythmias and sudden cardiac death. This correlation suggests a link between diabetes induced cardiac steatosis and electrical abnormalities, however, the underlying mechanism remains unknown. We previously showed that cardiac conduction velocity slows in Zucker diabetic fatty rats and in fructose‐fat fed rats, models that both exhibit prominent cardiac steatosis. The aim of this study was to investigate whether acute cardiac lipid accumulation reduces conduction velocity per se. Cardiac lipid accumulation was induced acutely by perfusing isolated rat hearts with palmitate‐glucose buffer, or subacutely by fasting rats overnight. Subsequently, longitudinal cardiac conduction velocity was measured in right ventricular tissue strips, and intramyocardial triglyceride and lipid droplet content was determined by thin layer chromatography and BODIPY staining, respectively. Perfusion with palmitate‐glucose buffer significantly increased intramyocardial triglyceride levels compared to perfusion with glucose (2.16 ± 0.17 (n = 10) vs. 0.92 ± 0.33 nmol/mg WW (n = 9), P < 0.01), but the number of lipid droplets was very low in both groups. Fasting of rats, however, resulted in both significantly elevated intramyocardial triglyceride levels compared to fed rats (3.27 ± 0.43 (n = 10) vs. 1.45 ± 0.24 nmol/mg WW (n = 10)), as well as a larger volume of lipid droplets (0.60 ± 0.13 (n = 10) vs. 0.21 ± 0.06% (n = 10), P < 0.05). There was no significant difference in longitudinal conduction velocity between palmitate‐glucose perfused and control hearts (0.77 ± 0.025 (n = 10) vs. 0.75 m/sec ± 0.029 (n = 9)), or between fed and fasted rats (0.75 ± 0.042 m/sec (n = 10) vs. 0.79 ± 0.047 (n = 10)). In conclusion, intramyocardial lipid accumulation does not slow cardiac longitudinal conduction velocity per se. This is true for both increased intramyocardial triglyceride content, induced by palmitate‐glucose perfusion, and increased intramyocardial triglyceride and lipid droplet content, generated by fasting.
- 1 April 2019
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 316 (4) , H849-H861
Modulating cardiac conduction during metabolic ischemia with perfusate sodium and calcium in guinea pig hearts
We previously demonstrated that altering extracellular sodium (Nao) and calcium (Cao) can modulate a form of electrical communication between cardiomyocytes termed “ephaptic coupling” (EpC), especially during loss of gap junction coupling. We hypothesized that altering Nao and Cao modulates conduction velocity (CV) and arrhythmic burden during ischemia. Electrophysiology was quantified by optically mapping Langendorff-perfused guinea pig ventricles with modified Nao (147 or 155 mM) and Cao (1.25 or 2.0 mM) during 30 min of simulated metabolic ischemia (pH 6.5, anoxia, aglycemia). Gap junction-adjacent perinexal width ( WP), a candidate cardiac ephapse, and connexin (Cx)43 protein expression and Cx43 phosphorylation at S368 were quantified by transmission electron microscopy and Western immunoblot analysis, respectively. Metabolic ischemia slowed CV in hearts perfused with 147 mM Nao and 2.0 mM Cao; however, theoretically increasing EpC with 155 mM Nao was arrhythmogenic, and CV could not be measured. Reducing Cao to 1.25 mM expanded WP, as expected during ischemia, consistent with reduced EpC, but attenuated CV slowing while delaying arrhythmia onset. These results were further supported by osmotically reducing WP with albumin, which exacerbated CV slowing and increased early arrhythmias during ischemia, whereas mannitol expanded WP, permitted conduction, and delayed the onset of arrhythmias. Cx43 expression patterns during the various interventions insufficiently correlated with observed CV changes and arrhythmic burden. In conclusion, decreasing perfusate calcium during metabolic ischemia enhances perinexal expansion, attenuates conduction slowing, and delays arrhythmias. Thus, perinexal expansion may be cardioprotective during metabolic ischemia. NEW & NOTEWORTHY This study demonstrates, for the first time, that modulating perfusate ion composition can alter cardiac electrophysiology during simulated metabolic ischemia.
- 1 April 2019
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 316 (4) , H849-H861
Modulating cardiac conduction during metabolic ischemia with perfusate sodium and calcium in guinea pig hearts
We previously demonstrated that altering extracellular sodium (Nao) and calcium (Cao) can modulate a form of electrical communication between cardiomyocytes termed “ephaptic coupling” (EpC), especially during loss of gap junction coupling. We hypothesized that altering Nao and Cao modulates conduction velocity (CV) and arrhythmic burden during ischemia. Electrophysiology was quantified by optically mapping Langendorff-perfused guinea pig ventricles with modified Nao (147 or 155 mM) and Cao (1.25 or 2.0 mM) during 30 min of simulated metabolic ischemia (pH 6.5, anoxia, aglycemia). Gap junction-adjacent perinexal width ( WP), a candidate cardiac ephapse, and connexin (Cx)43 protein expression and Cx43 phosphorylation at S368 were quantified by transmission electron microscopy and Western immunoblot analysis, respectively. Metabolic ischemia slowed CV in hearts perfused with 147 mM Nao and 2.0 mM Cao; however, theoretically increasing EpC with 155 mM Nao was arrhythmogenic, and CV could not be measured. Reducing Cao to 1.25 mM expanded WP, as expected during ischemia, consistent with reduced EpC, but attenuated CV slowing while delaying arrhythmia onset. These results were further supported by osmotically reducing WP with albumin, which exacerbated CV slowing and increased early arrhythmias during ischemia, whereas mannitol expanded WP, permitted conduction, and delayed the onset of arrhythmias. Cx43 expression patterns during the various interventions insufficiently correlated with observed CV changes and arrhythmic burden. In conclusion, decreasing perfusate calcium during metabolic ischemia enhances perinexal expansion, attenuates conduction slowing, and delays arrhythmias. Thus, perinexal expansion may be cardioprotective during metabolic ischemia. NEW & NOTEWORTHY This study demonstrates, for the first time, that modulating perfusate ion composition can alter cardiac electrophysiology during simulated metabolic ischemia.